LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.


(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...


(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...


(Alliance News) - Physiomics PLC on Friday said it "continues to make strong operational progress" but noted one-off costs from the dismissal of its p...


Biology company Physiomics won a contract with an unidentified drug company on Thursday, boosting its shares by 18.75%. Under the deal, Physiomics wi...


LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with ...


LONDON (Alliance News) - Retailers Marks & Spencer and WH Smith Thursday reported better performances than of late, but still saw their shares dec...


LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WI...


LONDON (Alliance News) - Physiomics PLC said Thursday that it will be demonstrating a new validation of its Virtual Tumour Clinical Platform at a work...


LONDON (Alliance News) - Physiomics PLC said Thursday that it is in discussions with pharmaceutical companies about starting the first project to use ...


LONDON (Alliance News) - Physiomics PLC Friday said its pretax loss narrowed in its first half as the company increased its customer base, significant...